Arena Pharmaceuticals Inc ROCE
¿Qué es el ROCE de Arena Pharmaceuticals Inc?
El ROCE de Arena Pharmaceuticals Inc es -85.23%
¿Cuál es la definición de ROCE?
El retorno sobre el capital empleado (ROCE) es una relación financiera que mide la rentabilidad de una empresa y la eficiencia con la que se utiliza su capital.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE de compañías en Sector Health Care en NASDAQ en comparadas con Arena Pharmaceuticals Inc
¿Qué hace Arena Pharmaceuticals Inc?
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
Empresas con roce similar a Arena Pharmaceuticals Inc
- Mersana Therapeutics Inc tiene ROCE de -86.13%
- Cidara Therapeutics Inc tiene ROCE de -86.02%
- Provention Bio tiene ROCE de -85.97%
- Avadel Pharmaceuticals plc tiene ROCE de -85.92%
- Future FinTech Inc tiene ROCE de -85.86%
- Angiodynamic Inc tiene ROCE de -85.31%
- Arena Pharmaceuticals Inc tiene ROCE de -85.23%
- Aimmune Therapeutics Inc tiene ROCE de -85.16%
- The McClatchy tiene ROCE de -85.09%
- Galmed Pharmaceuticals Ltd tiene ROCE de -84.75%
- Novan Inc tiene ROCE de -84.71%
- Hands Form Ltd tiene ROCE de -84.67%
- Sparq Corp tiene ROCE de -84.65%